Trading Window shall remain closed from 01-10-2025 till 48 hours after the declaration of UFR for the quarter ended September 30, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Samrat Pharmachem Limited has informed BSE that its trading window will remain closed from October 1, 2025 until 48 hours after the company declares its Un-Audited Financial Results for the quarter ended September 30, 2025. The closure is mandatory under SEBI's Insider Trading Regulations, 2015 and the company's own internal Code of Conduct. During this period, all designated persons and their immediate relatives are prohibited from buying, selling, or pledging shares of the company. The filing was signed by Nishant Kankaria, Company Secretary and Compliance Officer, on September 26, 2025.
This is a routine, mandatory compliance filing with no direct impact on the stock price. However, it indicates that the Q2 FY26 (July-September 2025) earnings announcement is coming up shortly, and the actual results could trigger a price move once the trading window reopens.